All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database von Reddy, K. R., Lim, J. K., Kuo, A., Di Bisceglie, A. M., Galati, J. S., Morelli, G., Everson, G. T., Kwo, P. Y., Brown, R. S., Sulkowski, M. S., Akuschevich, L., Lok, A. S., Pockros, P. J., Vainorius, M., Terrault, N. A., Nelson, D. R., Fried, M. W., Manns, M. P.

Volltext

Prevention of hepatocellular carcinoma with antiviral therapy von Di Bisceglie, A M

Volltext

Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy von Landis, C. S., Ghabril, M., Rustgi, V., Di Bisceglie, A. M., Maliakkal, B., Rockey, D. C., Vierling, J. M., Bajaj, J., Rowell, R., Santoro, M., Enriquez, A., Jurek, M., Mokhtarani, M., Coakley, D. F., Scharschmidt, B. F.

Volltext

Hepatitis C von Di Bisceglie, Adrian M

Volltext

Determination of hepatitis B phenotype using biochemical and serological markers von Di Bisceglie, A. M., Lombardero, M., Teckman, J., Roberts, L., Janssen, H. L. A., Belle, S. H., Hoofnagle, J. H., Lau, Daryl T‐Y, Chung, Raymond T., Smith, Coleman I., ‐Melman, Mauricio, Wong, David K., Juan, Joshua, Feld, Jordan, Yim, Colina, Heathcote, Jenny, Lee, William M., Perrillo, Robert, Do, Son, Han, Steven‐Huy B., Tran, Tram T., Terrault, Norah A., Khalili, Mandana, Cooper, Stewart L., Lok, Anna Suk‐Fong, Fontana, Robert J., Fried, Michael W., Patel, Keyur, Evon, Donna, Carithers, Robert C., Shuhart, Margaret, Kowdley, Kris V., Wang, Chia C., Sterling, Richard K., Ghany, Marc G., Jake Liang, T., Doo, Edward, Chang, Kyong‐Mi, Park, Jang‐June, Wahed, Abdus, Cloonan, Yona, Kleiner, David

Volltext

Hepatitis C and hepatocellular carcinoma von Di Bisceglie, Adrian M

Volltext

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy von Evon, D. M., Amador, J., Stewart, P., Reeve, B. B., Lok, A. S., Sterling, R. K., Di Bisceglie, A. M., Reau, N., Serper, M., Sarkar, S., Lim, J. K., Golin, C. E., Fried, M. W.

Volltext

GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study von Rodriguez-Torres, M., Glass, S., Hill, J., Freilich, B., Hassman, D., Di Bisceglie, A. M., Taylor, J. G., Kirby, B. J., Dvory-Sobol, H., Yang, J. C., An, D., Stamm, L. M., Brainard, D. M., Kim, S., Krefetz, D., Smith, W., Marbury, T., Lawitz, E.

Volltext

Method for Assessing the Soundscape in a Marine Artificial Environment von Benocci, R, Asnaghi, E, Bisceglie, A, Lavorano, S, Galli, P, Roman, H. E, Zambon, G

Volltext

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma von Khan, M.Akram, Combs, Connie S, Brunt, Elizabeth M, Lowe, Val J, Wolverson, Michael K, Solomon, Harvey, Collins, Brian T, Bisceglie, Adrian M.Di

Volltext

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C von Di Bisceglie, A. M., Ghalib, R. H., Hamzeh, F. M., Rustgi, V. K.

Volltext

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir von Sterling, R. K., Kuo, A., Rustgi, V. K., Sulkowski, M. S., Stewart, T. G., Fenkel, J. M., El‐Genaidi, H., Mah'moud, M. A., Abraham, G. M., Stewart, P. W., Akushevich, L., Nelson, D. R., Fried, M. W., Di Bisceglie, A. M.

Volltext

Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status von Di Bisceglie, Adrian M, Lyra, Andre C, Schwartz, Myron, Reddy, Rajender K, Martin, Paul, Gores, Gregory, Lok, Anna S.F, Hussain, Khozema B, Gish, Robert, Van Thiel, David H, Younossi, Zobair, Tong, Myron, Hassanein, Tarek, Balart, Luis, Fleckenstein, Jacquelyn, Flamm, Stephen, Blei, Andres, Befeler, Alex S

Volltext

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C von SNOW, K. K., BONKOVSKY, H. L., FONTANA, R. J., KIM, H.‐Y., STERLING, R. K., DI BISCEGLIE, A. M., MORGAN, T. R., DIENSTAG, J. L., GHANY, M. G.

Volltext

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease von Kim, W. Ray, Flamm, Steven L., Di Bisceglie, Adrian M., Bodenheimer, Henry C.

Volltext

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection von Afdhal, Nezam, Reddy, K. Rajender, Nelson, David R, Lawitz, Eric, Gordon, Stuart C, Schiff, Eugene, Nahass, Ronald, Ghalib, Reem, Gitlin, Norman, Herring, Robert, Lalezari, Jacob, Younes, Ziad H, Pockros, Paul J, Di Bisceglie, Adrian M, Arora, Sanjeev, Subramanian, G. Mani, Zhu, Yanni, Dvory-Sobol, Hadas, Yang, Jenny C, Pang, Phillip S, Symonds, William T, McHutchison, John G, Muir, Andrew J, Sulkowski, Mark, Kwo, Paul

Volltext

Natural history of hepatitis C: Its impact on clinical management von Di Bisceglie, Adrian M.

Volltext

Evaluating anti‐viral drug selection and treatment duration in HBeAg‐negative chronic hepatitis B: a cost‐effectiveness analysis von VEENSTRA, D. L., SPACKMAN, D. E., BISCEGLIE, A., KOWDLEY, K. V., GISH, R. G.

Volltext

Telaprevir for Previously Treated Chronic HCV Infection von McHutchison, John G, Manns, Michael P, Muir, Andrew J, Terrault, Norah A, Jacobson, Ira M, Afdhal, Nezam H, Heathcote, E. Jenny, Zeuzem, Stefan, Reesink, Hendrik W, Garg, Jyotsna, Bsharat, Mohammad, George, Shelley, Kauffman, Robert S, Adda, Nathalie, M.D, Adrian M. Di Bisceglie

Volltext

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection von Sulkowski, Mark S, Vargas, Hugo E, Di Bisceglie, Adrian M, Kuo, Alexander, Reddy, K. Rajender, Lim, Joseph K, Morelli, Giuseppe, Darling, Jama M, Feld, Jordan J, Brown, Robert S, Frazier, Lynn M, Stewart, Thomas G, Fried, Michael W, Nelson, David R, Jacobson, Ira M

Volltext